IP Library Granted Patent US 8,084,049
Granted Patent B2
US 8,084,049 · App. 10/517,592 · Granted Dec 27, 2011

Complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives

Assignee: Astion Dermatology A/S
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,084,049
App. No.
10/517,592
Granted
Dec 27, 2011
Kind
B2
Abstract

The present invention relates to novel combinations of fatty acid derivatives and pyridine carboxy derivatives, including fatty acid esters with glycerol and 3-carboxy pyridine derivatives such as niacinamide. Such combinations have surprisingly shown antiviral and anti-microbial activity and the use for the treatment of inflammatory conditions and infections is disclosed herein.

Claims (10)

1. A composition for the treatment of dermal inflammation, comprising a combination of

(i) glyceryl monocaprylate or an alkali metal salt thereof and

(ii) niacinamide or a salt thereof,

wherein the component (i) and the component (ii) are present in a molar ratio of between about 1:3 and 1:16.

2. The composition according to claim 1 , wherein the component (i) is racemic, enantiomerically enriched or enantiomerically pure 1-glyceryl-monocaprylate and wherein component (ii) is niacinamide.

3. The composition according to claim 1 , further comprising one or more excipient(s) or carrier(s) for the formulation of a pharmaceutical, or a cosmetic.

4. The composition according to claim 3 , further comprising one or more therapeutically active agents.

5. The composition according to claim 3 , formulated for topical, or transdermal administration.

6. The composition according to claim 5 , formulated for topical administration.

7. The composition according to claim 2 , wherein the 1-glyceryl monocaprylate and the niacinamide or a salt thereof, are present in a molar ratio of about 1:14 or about 2:7.

Assignments (9)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2019
From: CIPHER PHARMACEUTICALS INC.
To: ASTION PHARMA A/S
Reel/Frame 051382/0244 →
RELEASE OF SECURITY INTEREST Recorded Nov 9, 2017
From: ATHYRIUM OPPORTUNITIES II ACQUISITION LP, AS COLLATERAL AGENT (BY ITS GENERAL PARTNERS: ATHYRIUM OPPORTUNITIES ASSOCIATES II LP AND ATHYRIUM GP HOLDING LLC )
To: CIPHER PHARMACEUTICALS INC.
Reel/Frame 044084/0426 →
ASSET PURCHASE AGREEMENT Recorded Jul 11, 2016
From: ASTION PHARMA A/S
To: CIPHER PHARMACEUTICALS INC.
Reel/Frame 039301/0307 →
SECURITY AGREEMENT Recorded Apr 14, 2015
From: CIPHER PHARMACEUTICALS INC.
To: ATHYRIUM OPPRTUNITIES II ACQUISITION LP
Reel/Frame 035424/0227 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2015
From: ASTION PHARMA A/S
To: AP NEWCO A/S
Reel/Frame 035074/0149 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2015
From: ASTION DERMATOLOGY A/S
To: ASTION PHARMA A/S
Reel/Frame 035074/0070 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2015
From: ASTION PHARMA A/S
To: CIPHER PHARMACEUTICALS INC.
Reel/Frame 035074/0366 →
CHANGE OF NAME Recorded Mar 3, 2015
From: AP NEWCO A/S
To: ASTION PHARMA A/S
Reel/Frame 035113/0432 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2005
From: WEIDNER, MORTEN SLOTH
To: ASTION DERMATOLOGY A/S
Reel/Frame 017333/0578 →
Priority Claims (1)
DK 2002 00951 · Jun 20, 2002 · national
Continuity (2)
Provisional Application 60389879 · Jun 20, 2002
Related Publication 20060069131A1 · Mar 30, 2006